Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Trill Impact is a Swedish impact investment firm that focuses on mid-market private equity and venture capital investments, particularly in Northern Europe. Founded in 2019 by Jan Ståhlberg, the firm aims to combine financial outperformance with measurable impact in line with the UN Sustainable Development Goals. Through its dedicated Ventures arm, Trill Impact invests in life science companies, including those developing novel therapeutics, medical devices, and digital health solutions. The firm's healthcare portfolio spans various sectors, from specialized biotech firms like Cinclus Pharma to healthcare service providers like European Dental Group. Trill Impact operates with a strong focus on ESG and impact measurement, seeking to address global challenges through its investment strategy.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Trill Impact.